MYD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Myriad Genetics Inc

Watchlist Manager

Watchlist

Price: 3.233 EUR -2.39% Market Closed

Market Cap: €292.6m

M	Myriad Genetics Inc F:MYD	US
	Yara International ASA LSE:0O7D	NO
	Healthcare Realty Trust Inc F:HT0	US
A	Asahi Kasei Corp DUS:ASAA	JP
	Pattern SpA MIL:PTR	IT
L	La-Z-Boy Inc SWB:LAZ	US
D	Dolby Laboratories Inc SWB:FUO	US
T	TransAlta Corp F:TZ1	CA
	Globalstar Inc F:P8S	US
U	United Therapeutics Corp XMUN:UTH	US
C	CME Group Inc DUS:MX4A	US
	Wuling Motors Holdings Ltd F:6LY	HK

Profitability Summary

Myriad Genetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

69% > 70%

Negative Operating Margin

-8%

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-23% > -8%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-32%

Declining Net Margin

-21% > -48%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-11%

Free Cash Flow Margin is Increasing

-22% > -3%

Negative ROE

-77%

Negative 3Y Average ROE

Negative 3Y Average ROIC